AGGRASTAT

Brand name authorized in: Austria Australia Canada Cyprus Finland Hong Kong Lithuania Netherlands Singapore United Kingdom United States

Active ingredients

The drug AGGRASTAT contains one active pharmaceutical ingredient (API):

1 Tirofiban hydrochloride monohydrate
UNII 6H925F8O5J - TIROFIBAN HYDROCHLORIDE

Tirofiban is a non-peptidal antagonist of the GP IIb/IIIa receptor, an important platelet surface receptor involved in platelet aggregation. Tirofiban prevents fibrinogen from binding to the GP IIb/IIIa receptor, thus blocking platelet aggregation.

Read about Tirofiban

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
B01AC17
Tirofiban
B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC17

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
AU
Pharmaceutical Benefits Scheme
Identifier(s): 8350L
CA
Health Products and Food Branch
Identifier(s): 02240706
FI
Lääkealan turvallisuus- ja kehittämiskeskus
Identifier(s): 003088, 004450, 517391
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 76035, 76039
HK
Department of Health Drug Office
Identifier(s): 44541
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1013670
NL
Z-Index G-Standaard
Identifier(s): 14635054
NL
Z-Index G-Standaard, PRK
Identifier(s): 58742
SG
Health Sciences Authority
Identifier(s): 10931P
US
FDA, National Drug Code
Identifier(s): 25208-001, 25208-002